These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3763771)

  • 1. Endocrine and behavioural responses to methylphenidate in depression.
    Joyce PR; Donald RA; Nicholls MG; Livesey JH; Abbott RM
    Psychol Med; 1986 Aug; 16(3):531-40. PubMed ID: 3763771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postdexamethasone prolactin and cortisol: a biological state variable in depression.
    Klein HE; Seibold B; Bender W; Nedopil N; Albus M; Schmauss M
    Acta Psychiatr Scand; 1984 Sep; 70(3):239-47. PubMed ID: 6496148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone suppression test and mood response to methylphenidate in primary depression.
    Brown P; Brawley P
    Am J Psychiatry; 1983 Aug; 140(8):990-3. PubMed ID: 6346911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A relationship between prolactin levels and dexamethasone suppression test results in major depressive disorder.
    Joyce PR; Donald RA; Livesey JH
    J Affect Disord; 1985; 8(2):191-5. PubMed ID: 3157731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin response to dexamethasone: a study on normal controls and depressed patients.
    Rupprecht R; Barocka A; Jecht E; Noder M; Pichl J; Schwarz W
    Acta Psychiatr Scand; 1987 Aug; 76(2):139-43. PubMed ID: 3673636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine challenge tests in depression: a study of growth hormone, TRH and cortisol release.
    Barry S; Dinan TG
    J Affect Disord; 1990 Apr; 18(4):229-34. PubMed ID: 2140374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum postdexamethasone prolactin measures in depressive patients and control subjects.
    Maes M; Schotte C; Peeters D; D'Hondt P; Martin M; Blockx P; Minner B; Suy E; Cosyns P
    J Psychiatr Res; 1991; 25(3):109-16. PubMed ID: 1941707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dexamethasone suppression test and response to methylphenidate in depression.
    Sternbach H; Gwirtsman H; Gerner RH
    Am J Psychiatry; 1981 Dec; 138(12):1629-31. PubMed ID: 7304800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influences of dexamethasone levels on the predictive value of the DST for unipolar major depression and the relationships between post-dexamethasone cortisol and ACTH levels.
    Maes M; Minner B; Suy E
    J Affect Disord; 1989; 17(1):39-46. PubMed ID: 2544636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine and behavioral responses to methylphenidate in normal subjects.
    Joyce PR; Donald RA; Nicholls MG; Livesey JH; Abbott RM
    Biol Psychiatry; 1986 Sep; 21(11):1015-23. PubMed ID: 3741917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the cortisol suppression index and the dexamethasone suppression test.
    Laux G; Schlesser MA; Rush AJ; Orsulak P; Weissenburger J
    J Clin Psychiatry; 1984 Oct; 45(10):431-2. PubMed ID: 6480568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls.
    Holsboer F; Gerken A; Steiger A; Fass V
    Acta Psychiatr Scand; 1984 May; 69(5):383-90. PubMed ID: 6730994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma dexamethasone and cortisol levels in depressed outpatients.
    Asnis GM; Friedman JM; Miller AH; Iqbal N; Lo ES; Cooper TB; Halbreich U; Lemus CZ; van Praag HM; Rubinson E
    J Affect Disord; 1989; 16(1):5-10. PubMed ID: 2521652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine responses after thyrotrophin-releasing hormone stimulation and dexamethasone suppression tests in the major depressive syndrome.
    Aalbers C; Taljaard JJ; Gagiano CA
    S Afr Med J; 1986 Oct; 70(8):464-8. PubMed ID: 3095937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic caffeine consumption and the dexamethasone suppression test in depression.
    Lee MA; Flegel P; Cameron OG; Greden JF
    Psychiatry Res; 1988 Apr; 24(1):61-5. PubMed ID: 3393618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression test and noradrenergic function in affective and schizophrenic disorders.
    Sora I; Nishimon K; Otsuki S
    Biol Psychiatry; 1986 Jun; 21(7):621-31. PubMed ID: 3708036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive relationship between the catecholaminergic turnover and the DST results in depression.
    Maes M; Vandewoude M; Schotte C; Martin M; Blockx P
    Psychol Med; 1990 Aug; 20(3):493-9. PubMed ID: 2173010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of beta-endorphin, cortisol, prolactin and growth hormone in depressed patients.
    Galard R; Gallart J; Arguello JM; Schwartz S; Castellanos JM; Catalán R
    Acta Psychiatr Scand; 1988 Aug; 78(2):230-3. PubMed ID: 2975911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.